4Trenton A, Currier G, Zuener F. Fatalities associated with therapeutic use and overdose of atypical antipsychotics[ J]. CNS Drugs, 2003,177 (5) : 307 - 324.
5Ahmet Akyol, A Can Senel, Hulya Ulusoy, et al. Delayed respiratory depression after risperidone overdose [ J ]. Anesth Analg, 2005, 101 : 1490 - 1491.
6Hirofumi Nishikage, Takeshi Nakanishi, Yoshihiro Takamitsu. Sequential Changes in the Plasma Concentration of Risperidone Following Intentional Overdose [ J ]. Clinical Neuropharmacology, 2002,25(6) : 307 -309.
二级参考文献27
1Chakos M, Lieberman J, Hoffman E, et al. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Am J Psychiatry, 2001, 158:518-526.
2Kane JM, Marder SR, Schooler NR, et al. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison. Arch Gen Psychiatry, 2001, 58:965-972.
3Bhana N, Foster RH, Olney R,et al. Olanzapine: an updated review of its use in the management of schizophrenia. Drugs, 2001, 61:111-161.
4Love RC, Nelson MW. Pharmacology and clinical experience with risperidone. Expert Opin Pharmacother, 2000, 1:1441-1453.
5Feltus MS, Gardner DM. Second generation antipsychotics for schizophrenia. Can J Clin Pharmacol, 1999, 6:187-195.
6Conley RR, Love RC, Kelly DL, et al. Rehospitalization rates of patients recently discharged on a regimen of risperidone or clozapine. Am J Psychiatry, 1999, 156:863-868.
7Meltzer H.Side effects of antipsychotic medications: physician's choice of medication and patient compliance[editorial]. J Clin Psychiatry, 2000, 61 Suppl 8:3-66.
8McCombs JS, Nichol MB, Stimmel GL, et al. Use patterns for antipsychotic medications in medicaid patients with schizophrenia. J Clin Psychiatry, 1999, 60 Suppl 19:5-11.
9Kane JM, Aguglia E, Altamura AC, et al. Guidelines for depot antipsychotic treatment in schizophrenia. Eur Neurop-sychopharmacol, 1998, 8:55 -66.
10Kane J, Honigfeld G, Singer J, et al. Clozapine for the treatment-resistant schizophrenic:a double-blind comparison with chlorpromazine. Arch Gen Psychiatry, 1988, 45:789-796.